Bone Biologics Corp. Files 8-K on Officer/Director Changes
Ticker: BBLGW · Form: 8-K · Filed: May 30, 2025 · CIK: 1419554
| Field | Detail |
|---|---|
| Company | Bone Biologics Corp (BBLGW) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: BBLG
TL;DR
Bone Biologics (BBLG) filed an 8-K today covering exec changes & votes. Watch for updates.
AI Summary
Bone Biologics Corp. filed an 8-K on May 30, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing indicates significant corporate governance and potential executive changes within Bone Biologics Corp., which could impact the company's strategic direction and operational leadership.
Risk Assessment
Risk Level: medium — Changes in directors or officers, especially when combined with votes of security holders, can signal underlying strategic shifts or internal challenges.
Key Players & Entities
- Bone Biologics Corp. (company) — Filer of the 8-K report
- May 30, 2025 (date) — Date of the earliest event reported
FAQ
What specific items were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text.
Were there any departures of directors or officers mentioned?
Yes, the filing explicitly lists 'Departure of Directors or Certain Officers' as an item of information being reported.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the company's Standard Industrial Classification code?
The SIC code is 3842, for 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
What is the filing date of this 8-K report?
The filing date, and the date of the earliest event reported, is May 30, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding Bone Biologics Corp (BBLGW).